Top

Intensive Care Medicine

Published in:

01-12-2016 | Correspondence

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis—response to comments by Ranzani et al.

Authors: Muriel Rabilloud, Claude Guérin

Published in: Intensive Care Medicine | Issue 12/2016

Excerpt

Dear Editor, …

Ranzani OT, Li Bassi G, Torres A (2016) Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis. Intensive Care Med. doi:10.1007/s00134-016-4469-2 PubMed

Ayzac L, Girard R, Baboi L, Beuret P, Rabilloud M, Richard JC, Guérin C (2016) Ventilator-associated pneumonia in ARDS patients: the impact of prone positioning. A secondary analysis of the PROSEVA trial. Intensive Care Med 42:871–878. doi:10.1007/s00134-015-4167-5 CrossRefPubMed

Latouche A, Allignol A, Beyersmann J, Labopin L, Fine JP (2013) A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 66:648–653CrossRefPubMed

Beyersmann J, Schumacher M, Allignol A (2012) Competing risks and multistate models with R. Springer, New York, pp 89–153CrossRef

Title: Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis—response to comments by Ranzani et al.
Authors: Muriel Rabilloud
Claude Guérin
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 12/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4548-4

At a glance: The STEP trials

Springer Medicine

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis—response to comments by Ranzani et al.

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2016

Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia

Understanding why resistant bacteria are associated with higher mortality in ICU patients

Understanding circulatory failure in sepsis

Factors affecting biomarkers of endothelial and alveolar epithelial dysfunction: response to comments by Kyo et al.

Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

Transforming ICU death into life—radically more